HealthEdge-backed Veridian closes acquisition of ScarScience brand from Mitchell-Vance Laboratories

Published on September 21, 2026

The deal strengthens Veridian's position in scar and wound care and extends its reach in plastic surgery, dermatology, and physical therapy.

The post HealthEdge-backed Veridian closes acquisition of ScarScience brand from Mitchell-Vance Laboratories appeared first on PE Hub.

Continue reading on website
Other news

Telix Pharmaceuticals to acquire and merge with BlackRock-backed ITM for up to $2.35bn

September 21, 2026
Telix will pay $1.65 billion in cash upfront for 100 percent of ITM's shares, plus up to $700 million in contingency payments.The post Telix Pharmaceuticals to acquire and merge with BlackRock-backed ITM for up to $2.35bn appeared first on PE Hub.